Literature DB >> 8796980

Molecular and cellular interactions in rheumatoid synovium.

U Müller-Ladner1.   

Abstract

There is growing evidence that distinct molecular and cellular interactions in the rheumatoid synovium result in a complex cascade of pathophysiologic events. These interactions finally lead to progressive joint destruction, in a way that is different from all other joint diseases. Keystones are inflammation, proliferation of synovial cells, and attachment and invasion of synovial fibroblasts (in)to adjacent cartilage and bone, mediated by continuous release of matrix-degrading enzymes. Advances in molecular biology have provided numerous new data on the rheumatoid arthritis interaction cascade. Major research topics involve the balance of proinflammatory and inhibitory cytokines, the role of adhesion molecules in attachment of synovial fibroblasts to cartilage, and the localization of various matrix-degrading enzymes in the synovial lining. The results of the research reviewed here also provide a basis for future therapies including gene therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796980     DOI: 10.1097/00002281-199605000-00008

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  6 in total

1.  Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression.

Authors:  M F Neurath; K Hildner; C Becker; J F Schlaak; K Barbulescu; T Germann; E Schmitt; P Schirmacher; S Haralambous; M Pasparakis; K H Meyer Zum Büschenfelde; G Kollias; E Märker-Hermann
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.

Authors:  S Sakuma; Y Kato; F Nishigaki; T Sasakawa; K Magari; S Miyata; Y Ohkubo; T Goto
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis.

Authors:  S Wakisaka; N Suzuki; M Takeno; Y Takeba; H Nagafuchi; N Saito; H Hashimoto; T Tomita; T Ochi; T Sakane
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

Review 4.  New therapeutic targets for rheumatoid arthritis.

Authors:  H J Dinant; B A Dijkmans
Journal:  Pharm World Sci       Date:  1999-04

5.  Ganghwaljetongyeum, an anti-arthritic remedy, attenuates synoviocyte proliferation and reduces the production of proinflammatory mediators in macrophages: the therapeutic effect of GHJTY on rheumatoid arthritis.

Authors:  Bo-Ram Jeoung; Kyung Dong Lee; Chang-Su Na; Young-Eok Kim; BoA Kim; Young Ran Kim
Journal:  BMC Complement Altern Med       Date:  2013-02-26       Impact factor: 3.659

6.  High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.

Authors:  Peter Ruschpler; Peter Lorenz; Wolfram Eichler; Dirk Koczan; Claudia Hänel; Roger Scholz; Christian Melzer; Hans-Jürgen Thiesen; Peter Stiehl
Journal:  Arthritis Res Ther       Date:  2003-06-26       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.